Evaluation of Systemic Antifungal Use in a Latin American General Care Hospital: A Retrospective Study.

Abigail Fallas-MoraJose Pablo Díaz-MadrizJose Miguel Chaverri-Fernández Esteban Zavaleta-Monestel

Published in: Pharmacy (Basel, Switzerland) (2023)

Comorbidities and risk factors in patients receiving systemic antifungals can be associated with the development of more serious fungal infections; hence, the implementation of antifungal stewardship as a complement to antimicrobial stewardship programs can help facilitate decision-making when dealing with a suspected case of fungal infection.

Keyphrases

healthcare
candida albicans
risk factors
decision making
quality improvement
acute care
palliative care
primary care
public health
cell wall
drug induced
pain management
adverse drug
chronic pain